SGLT2 Inhibitors for Cardioprotection

Affiliations

¹ Department of Pharmacology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, India.
² Department of Pharmacology, Bhaarath Medical College and Hospital, Bharath Institute of Higher Education and Research, Chennai, India.
³ Department of Pharmacology, Jawaharlal Nehru Medical College Hospital, Aligarh Muslim University, Aligarh, India.

Editorial

Sulthan Al Rashid et al. Oman Med J. 2023.

. 2023 Jul 31;38(4):e521.

doi: 10.5001/omj.2023.128. eCollection 2023 Jul.

¹ Department of Pharmacology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, India.
² Department of Pharmacology, Bhaarath Medical College and Hospital, Bharath Institute of Higher Education and Research, Chennai, India.
³ Department of Pharmacology, Jawaharlal Nehru Medical College Hospital, Aligarh Muslim University, Aligarh, India.

No abstract available

References

1. Briasoulis A, Al Dhaybi O, Bakris GL. SGLT2 inhibitors and mechanisms of hypertension. Curr Cardiol Rep 2018. Jan;20(1):1. 10.1007/s11886-018-0943-5 - DOI - PubMed
1. Ni L, Yuan C, Chen G, Zhang C, Wu X. SGLT2i: beyond the glucose-lowering effect. Cardiovasc Diabetol 2020. Jun;19(1):98. 10.1186/s12933-020-01071-y - DOI - PMC - PubMed
1. Mazzali M, Kanbay M, Segal MS, Shafiu M, Jalal D, Feig DI, et al. . Uric acid and hypertension: cause or effect? Curr Rheumatol Rep 2010. Apr;12(2):108-117. 10.1007/s11926-010-0094-1 - DOI - PubMed
1. Zhang Q, Zhou S, Liu L. Efficacy and safety evaluation of SGLT2i on blood pressure control in patients with type 2 diabetes and hypertension: a new meta-analysis. Diabetol Metab Syndr 2023. Jun;15(1):118. 10.1186/s13098-023-01092-z - DOI - PMC - PubMed
1. Saucedo-Orozco H, Voorrips SN, Yurista SR, de Boer RA, Westenbrink BD. SGLT2 inhibitors and ketone metabolism in heart failure. J Lipid Atheroscler 2022. Jan;11(1):1-19. 10.12997/jla.2022.11.1.1 - DOI - PMC - PubMed